BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $18,120,000 | -29.3% | 275,000 | -45.8% | 1.02% | -37.2% |
Q2 2022 | $25,627,000 | -20.9% | 507,374 | 0.0% | 1.62% | -2.6% |
Q1 2022 | $32,411,000 | -40.4% | 507,374 | 0.0% | 1.67% | -21.1% |
Q4 2021 | $54,345,000 | +24.4% | 507,374 | +19.4% | 2.11% | +38.3% |
Q3 2021 | $43,694,000 | +90.6% | 425,000 | +70.0% | 1.53% | -37.6% |
Q1 2018 | $22,925,000 | +21.6% | 250,000 | 0.0% | 2.45% | -29.0% |
Q4 2017 | $18,853,000 | +8.2% | 250,000 | 0.0% | 3.45% | -13.1% |
Q3 2017 | $17,418,000 | +37.5% | 250,000 | 0.0% | 3.96% | +31.6% |
Q2 2017 | $12,668,000 | -58.9% | 250,000 | -67.5% | 3.01% | -55.2% |
Q1 2017 | $30,799,000 | +55.7% | 770,159 | +9.2% | 6.73% | -12.0% |
Q4 2016 | $19,780,000 | -5.6% | 705,159 | 0.0% | 7.65% | -18.5% |
Q3 2016 | $20,943,000 | +46.7% | 705,159 | 0.0% | 9.39% | -25.9% |
Q2 2016 | $14,279,000 | +12.2% | 705,159 | 0.0% | 12.66% | +1.7% |
Q1 2016 | $12,728,000 | +54.1% | 705,159 | +124.8% | 12.46% | +74.6% |
Q4 2015 | $8,261,000 | – | 313,626 | – | 7.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |